ABBOTT LABORATORIES Shareholders' Equity
ABBOTT LABORATORIES (ABT) had Shareholders' Equity of $52.06 billion as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-29
- 2026-03-31: Stockholders' Equity Attributable to Parent $52.06B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $52.13B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $50.95B.
- 2025-06-30: Stockholders' Equity Attributable to Parent $50.56B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $52.06B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $52.13B 10-Q · filed 2026-04-29 | |
| 2025-09-30 | $50.95B 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $50.56B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $48.81B 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $47.66B 10-K · filed 2026-02-20 | |
| 2024-09-30 | $39.80B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $39.32B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $38.81B 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $38.60B 10-K · filed 2025-02-21 | |
| 2023-09-30 | $37.48B 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $37.17B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $37.01B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $36.69B 10-K · filed 2024-02-16 | |
| 2022-09-30 | $35.67B 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $36.49B 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $35.40B 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $35.80B 10-K · filed 2023-02-17 | |
| 2021-09-30 | $34.42B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $33.80B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $33.56B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $32.78B 10-K · filed 2022-02-18 | |
| 2020-09-30 | $31.39B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $30.58B 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $30.22B 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $31.09B 10-K · filed 2021-02-19 | |
| 2019-09-30 | $31.82B 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $31.69B 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $30.93B 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $30.52B 10-K · filed 2020-02-21 | |
| 2018-09-30 | $30.70B 10-Q · filed 2018-10-31 | |
| 2018-06-30 | $30.58B 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $31.40B 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $30.90B 10-K · filed 2019-02-22 | |
| 2017-09-30 | $32.03B 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $31.60B 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $31.36B 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $20.54B 10-K · filed 2018-02-16 | |
| 2016-09-30 | $20.78B 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $20.68B 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $20.72B 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $21.21B 10-K · filed 2017-02-17 | |
| 2015-09-30 | $21.11B 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $23.01B 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $21.87B 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $21.53B 10-K · filed 2016-02-19 | |
| 2014-09-30 | $22.89B 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $23.60B 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $23.39B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $25.17B 10-K · filed 2015-02-27 | |
| 2013-09-30 | $23.70B 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $22.34B 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $22.59B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $26.72B 10-K · filed 2014-02-21 | $26.72B 10-K · filed 2013-02-15 |
| 2012-09-30 | $27.01B 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $24.49B 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $25.45B 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $24.44B 10-K · filed 2013-02-15 | |
| 2011-09-30 | $24.60B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $26.38B 10-Q · filed 2011-08-04 | |
| 2011-03-31 | $24.63B 10-Q · filed 2011-05-06 | |
| 2010-12-31 | $22.68B 10-K · filed 2013-02-15 | $22.39B 10-K · filed 2011-02-18 |
| 2010-09-30 | $21.40B 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $19.91B 10-Q · filed 2010-08-05 | |
| 2010-03-31 | $20.86B 10-Q · filed 2010-05-04 | |
| 2009-12-31 | $23.14B 10-K · filed 2012-02-21 | $22.86B 10-K · filed 2010-02-19 |
| 2009-09-30 | $21.34B 10-Q · filed 2009-11-06 | |
| 2009-06-30 | $19.88B 10-Q · filed 2009-08-07 | |
| 2008-12-31 | $17.48B 10-K · filed 2011-02-18 | |
| 2007-12-31 | $17.78B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |